Correlation Between Albemarle and AstraZeneca PLC

Can any of the company-specific risk be diversified away by investing in both Albemarle and AstraZeneca PLC at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Albemarle and AstraZeneca PLC into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Albemarle and AstraZeneca PLC, you can compare the effects of market volatilities on Albemarle and AstraZeneca PLC and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Albemarle with a short position of AstraZeneca PLC. Check out your portfolio center. Please also check ongoing floating volatility patterns of Albemarle and AstraZeneca PLC.

Diversification Opportunities for Albemarle and AstraZeneca PLC

-0.76

Correlation Coefficient

Albemarle  AstraZeneca PLC

Pay attention - limited upside

The 3 months correlation between Albemarle and AstraZeneca is -0.76. Overlapping area represents the amount of risk that can be diversified away by holding Albemarle and AstraZeneca PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AstraZeneca PLC and Albemarle is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Albemarle are associated (or correlated) with AstraZeneca PLC. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AstraZeneca PLC has no effect on the direction of Albemarle i.e., Albemarle and AstraZeneca PLC go up and down completely randomly.

Pair Corralation between Albemarle and AstraZeneca PLC

Assuming the 90 days horizon Albemarle is expected to generate 2.06 times more return on investment than AstraZeneca PLC. However, Albemarle is 2.06 times more volatile than AstraZeneca PLC. It trades about 0.12 of its potential returns per unit of risk. AstraZeneca PLC is currently generating about -0.14 per unit of risk. If you would invest  7,829  in Albemarle on September 4, 2024 and sell it today you would earn a total of  2,363  from holding Albemarle or generate 30.18% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Albemarle  vs.  AstraZeneca PLC

Albemarle

Risk-Adjusted Performance

9 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Albemarle are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Albemarle reported solid returns over the last few months and may actually be approaching a breakup point.

AstraZeneca PLC

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days AstraZeneca PLC has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Pair Trading with Albemarle and AstraZeneca PLC

The main advantage of trading using opposite Albemarle and AstraZeneca PLC positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Albemarle position performs unexpectedly, AstraZeneca PLC can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AstraZeneca PLC will offset losses from the drop in AstraZeneca PLC's long position.

The idea behind Albemarle and AstraZeneca PLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.